Literature DB >> 18057428

The prevalence of cardiovascular risk factors in male patients who have lower urinary tract symptoms.

C F Ng1, A Wong, M L Li, S Y Chan, S K Mak, W S Wong.   

Abstract

OBJECTIVES: To assess the prevalence of cardiovascular risk factors in men presenting with lower urinary tract symptoms, and their possible correlation with the severity of such symptoms.
DESIGN: Retrospective cohort study.
SETTING: Specialty clinic, Hong Kong. PATIENTS: A total of 617 men presenting with lower urinary tract symptoms between April 2005 and October 2006. MAIN OUTCOME MEASURES: Presence of cardiovascular risk factors inferred from the prior and current medical and social history as well as physical examination and investigative findings, among patients with International Prostatic Symptom Scores of different severity.
RESULTS: Of 617 patients, 268 (43%) had known hypertension and 318 (52%) had a history of smoking. According to the World Health Organization criteria for Asian populations, 396 (64%) patients were considered to be overweight (body mass index > or =23 kg/m(2)). A total of 178 (29%) patients were either known to have or were diagnosed to have dysglycaemia during workup. For dyslipidaemia and hyperuricaemia, the corresponding figures were 331 (54%) and 191 (31%). In total, 264 (43%) patients were newly diagnosed as having dysglycaemia, dyslipidaemia, or hyperuricaemia. Logistic regression indicated that only hyperuricaemia and a smoking history were significant predictors of moderate-to-severe lower urinary tract symptoms (International Prostatic Symptom Score > or =8), with respective adjusted odds ratios of 2.20 (95% confidence interval, 1.12-4.31; P=0.022) and 2.11 (1.24-3.57, P=0.006). Patients with moderate-to-severe International Prostatic Symptom Scores had a statistically higher chance of having at least one cardiovascular risk factor during assessment (P=0.001).
CONCLUSIONS: Cardiovascular risk factors were prevalent in male patients who had lower urinary tract symptoms; a large portion of these cardiovascular risk factors were not recognised until their urological consultations. Patients with moderate-to-severe lower urinary tract symptoms (International Prostatic Symptom Score > or =8) had statistically higher chances of having more cardiovascular risk factors.

Entities:  

Mesh:

Year:  2007        PMID: 18057428

Source DB:  PubMed          Journal:  Hong Kong Med J        ISSN: 1024-2708            Impact factor:   2.227


  6 in total

1.  Are lower urinary tract symptoms associated with cardiovascular disease in the Dutch general population? Results from the Krimpen study.

Authors:  Inge I Bouwman; Marco H Blanker; Boris W V Schouten; Arthur M Bohnen; Rien J M Nijman; Wouter K van der Heide; J L H Ruud Bosch
Journal:  World J Urol       Date:  2014-09-25       Impact factor: 4.226

Review 2.  Do lower urinary tract symptoms predict cardiovascular diseases in older men? A systematic review and meta-analysis.

Authors:  Iris I Bouwman; Maarten J H Voskamp; Boudewijn J Kollen; Rien J M Nijman; Wouter K van der Heide; Marco H Blanker
Journal:  World J Urol       Date:  2015-05-14       Impact factor: 4.226

3.  Association of lower urinary tract syndrome with peripheral arterial occlusive disease.

Authors:  Wei-Yu Lin; Karl-Erik Andersson; Cheng-Li Lin; Chia-Hung Kao; Hsi-Chin Wu
Journal:  PLoS One       Date:  2017-03-16       Impact factor: 3.240

Review 4.  Cellular Stress and Molecular Responses in Bladder Ischemia.

Authors:  Jing-Hua Yang; Han-Pil Choi; Wanting Niu; Kazem M Azadzoi
Journal:  Int J Mol Sci       Date:  2021-11-01       Impact factor: 5.923

5.  Medical attendance for lower urinary tract symptoms is associated with subsequent increased risk of outpatient visits and hospitalizations based on a nationwide population-based database.

Authors:  Ming-Ping Wu; Shih-Feng Weng; Ya-Wen Hsu; Jhi-Joung Wang; Hann-Chorng Kuo
Journal:  PLoS One       Date:  2013-03-05       Impact factor: 3.240

6.  Are lower urinary tract symptoms in men associated with cardiovascular diseases in a primary care population: a registry study.

Authors:  Inge I Bouwman; Boudewijn J Kollen; Klaas van der Meer; Rien J M Nijman; Wouter K van der Heide
Journal:  BMC Fam Pract       Date:  2014-01-14       Impact factor: 2.497

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.